NEMOLIZUMAB

UNII:	GN465U8B72
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	NEMOLIZUMAB
GSRS Full Record:	GN465U8B72 i

1476039-58-3
CIM-331
CIM331
Immunoglobulin G2, anti-(interleukin 31 receptor A) (human-Mus musculus monoclonal CIM331 γ-chain), disulfide with human-Mus musculus monoclonal CIM331 κ-chain, dimer
NEMLUVIO
NEMOLIZUMAB [JAN]
NEMOLIZUMAB [USAN]
Nemolizumab
Nemolizumab [MI]
Nemolizumab [WHO-DD]
Nemolizumab ilto [WHO-DD]
Nemolizumab-ILTO
immunoglobulin G2-kappa, anti-[Homo sapiens IL31RA (interleukin 31 receptor subunit alpha)], humanized monoclonal antibody gamma2 heavy chain (1-445) [humanized VH (Homo sapiens IGHV1-2*02 (83.70%) -(IGHD)-IGHJ5*01) [8.8.14] (1-121) -Homo sapiens IGHG2*01 (CH1 C10>S (135), R12>K (137), E16>G (141), S17>G (142) (122-219), hinge C4>S (223) (220-231), CH2 H30>Q (268) (232-340), CH3 R11>Q (355), Q98>E (419) (341-445)) (122-445)], (224-214')-disulfide with kappa light chain (1’-214’) [humanized V-KAPPA (Homo sapiens IGKV1-39*01 (82.10%) -IGKJ4*01) [6.3.9] (1'-107') -Homo sapiens IGKC*01 (108'-214')]; dimer (227-227":230-230")-bisdisulfide
nemolizumab [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

NEMOLIZUMAB

Synonyms and Mappings

Resources